Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/FCF ratio is N/A as of 2026-10-06T19:12:58.496Z.

Stored calculation inputs

Calculation as of: 2026-10-06T19:12:58.496Z.

Quote observation: 2026-10-06T19:10:15.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 20,217,263
Total debt · period ending 2026-06-30: 4,287,000
Cash · period ending 2026-06-30: 15,260,000
TTM free cash flow · period ending 2026-06-30: -36,984,000

FMP input reference: 733e4da94f9494cd21c7af02f5120fd8528014c079e3dffba0957966aae51245

Free Cash Flow|FCF Yield|P/FCF Ratio|EV/EBITDA|All Metrics

NXTC EV/FCF Ratio Metrics

EV/FCF RATIO

N/A

EV/FCF RATIO AVG TTM

N/A

EV/FCF RATIO AVG 3Y

N/A

EV/FCF RATIO AVG 5Y

N/A

EV/FCF RATIO AVG 10Y

N/A

EV/FCF RATIO AVG 15Y

N/A

EV/FCF RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

N/A

CURRENT VS 3Y AVG

N/A

CURRENT VS 5Y AVG

N/A

CURRENT VS 10Y AVG

N/A

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

NXTC Competitors' EV/FCF Ratio

NXTC

NextCure, Inc.

Current

Market Cap

$20.22M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

QNTM

Quantum BioPharma Ltd.

vs NXTC

Market Cap

$20.44M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PIII

P3 Health Partners Inc.

vs NXTC

Market Cap

$19.79M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NEUP

Neuphoria Therapeutics Inc.

vs NXTC

Market Cap

$18.62M

EV/FCF Ratio

N/A

TTM Avg

281.92x

3Y Avg

1403.45x

5Y Avg

1403.45x

AYTU

Aytu BioPharma, Inc.

vs NXTC

Market Cap

$21.79M

EV/FCF Ratio

4.18x

TTM Avg

11.24x

3Y Avg

10.04x

5Y Avg

10.04x

ACTU

Actuate Therapeutics Inc

vs NXTC

Market Cap

$18.64M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MODD

Modular Medical, Inc.

vs NXTC

Market Cap

$22.09M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LONA

LeonaBio, Inc.

vs NXTC

Market Cap

$22.24M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

COSM

Cosmos Health Inc.

vs NXTC

Market Cap

$18.06M

EV/FCF Ratio

N/A

TTM Avg

14.44x

3Y Avg

40.11x

5Y Avg

40.11x

ESLA

Estrella Immunopharma, Inc.

vs NXTC

Market Cap

$17.99M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/FCF RATIO	TTM	3Y	5Y
NextCure, Inc. (NXTC)	$20.22M	N/A	N/A	N/A	N/A
Quantum BioPharma Ltd. (QNTM)vs ›	$20.44M	N/A	N/A	N/A	N/A
P3 Health Partners Inc. (PIII)vs ›	$19.79M	N/A	N/A	N/A	N/A
Neuphoria Therapeutics Inc. (NEUP)vs ›	$18.62M	N/A	281.92x	1403.45x	1403.45x
Aytu BioPharma, Inc. (AYTU)vs ›	$21.79M	4.18x	11.24x	10.04x	10.04x
Actuate Therapeutics Inc (ACTU)vs ›	$18.64M	N/A	N/A	N/A	N/A
Modular Medical, Inc. (MODD)vs ›	$22.09M	N/A	N/A	N/A	N/A
LeonaBio, Inc. (LONA)vs ›	$22.24M	N/A	N/A	N/A	N/A
Cosmos Health Inc. (COSM)vs ›	$18.06M	N/A	14.44x	40.11x	40.11x
Estrella Immunopharma, Inc. (ESLA)vs ›	$17.99M	N/A	N/A	N/A	N/A

Cash Flow Valuation Comparison

EV/FCF

N/A

P/FCF

N/A

FCF Yield

N/A

Formula: EV/FCF = Enterprise Value / Free Cash Flow

EV/FCF vs P/FCF:

EV/FCF accounts for debt and cash through enterprise value
P/FCF only considers equity value
EV/FCF can be compared across companies with different debt levels
Both measure how the market values cash generation

EV/FCF Ratio Formula & Definition

EV/FCF = Enterprise Value / Free Cash Flow (TTM)

Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

NXTC EV/FCF Ratio History

DATE	EV/FCF RATIO
2019-08-12	197.09x
2019-08-09	193.66x
2019-08-08	181.79x
2019-08-07	198.76x
2019-08-06	185.43x
2019-08-05	169.09x
2019-08-02	174.29x
2019-08-01	176.38x
2019-07-31	173.46x
2019-07-30	162.43x
2019-07-29	158.68x
2019-07-26	150.56x
2019-07-25	150.35x
2019-07-24	144.83x
2019-07-23	138.80x
2019-07-22	146.08x
2019-07-19	143.48x
2019-07-18	127.45x
2019-07-17	116.52x
2019-07-16	114.23x
2019-07-15	117.25x
2019-07-12	119.43x
2019-07-11	121.83x
2019-07-10	118.08x
2019-07-09	121.20x
2019-07-08	108.50x
2019-07-05	117.87x
2019-07-03	120.58x
2019-07-02	122.77x
2019-07-01	128.49x
2019-06-28	100.70x
2019-06-27	92.16x
2019-06-26	94.66x
2019-06-25	94.03x
2019-06-24	96.32x
2019-06-21	96.95x
2019-06-20	102.67x
2019-06-19	105.28x
2019-06-18	106.32x
2019-06-17	102.15x
2019-06-14	106.42x
2019-06-13	106.84x
2019-06-12	95.59x
2019-06-11	105.59x
2019-06-10	354.69x
2019-06-07	377.66x
2019-06-06	379.62x
2019-06-05	369.84x
2019-06-04	405.52x
2019-06-03	396.72x
2019-05-31	427.76x
2019-05-30	441.45x
2019-05-29	420.92x
2019-05-28	454.64x
2019-05-24	459.04x
2019-05-23	450.98x
2019-05-22	458.56x
2019-05-21	461.73x
2019-05-20	477.13x
2019-05-17	456.60x
2019-05-16	465.89x
2019-05-15	461.73x
2019-05-14	448.78x
2019-05-13	446.82x
2019-05-10	449.27x
2019-05-09	459.04x

EV/FCF Ratio: N/A

NXTC EV/FCF Ratio Chart

NXTC EV/FCF Ratio Metrics

NXTC Competitors' EV/FCF Ratio

Cash Flow Valuation Comparison

EV/FCF Ratio Formula & Definition

NXTC EV/FCF Ratio History

Related Metrics